Efficiency of the estimation of physiologic ability and surgical stress (E-PASS) score in predicting postoperative complications after robot-assisted radical prostatectomy
Turkish Journal of Trauma and Emergency Surgery · 2024
DOI: 10.14744/tjtes.2024.36332 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Trauma and Emergency Surgery, 2024. Verfasst von Süleyman Bulut und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Ankara Bilkent City Hospital, Ankara-Türkiye. Hauptthemen laut MEDLINE: Prostatectomy, Postoperative Complications, Robotic Surgical Procedures, Prostatic Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND: Robot-Assisted Radical Prostatectomy (RARP) is increasingly becoming the standard surgical treatment for prostate cancer. While some risk factors for postoperative complications of RARP have been identified, no scoring model that incorporates both preoperative physical status of the patient and intraoperative risk factors has been developed. The Estimation of Physiologic Ability and Surgical Stress (E-PASS) score was initially described to predict postoperative complications after gastrointestinal surgical procedures. This study aims to assess the effectiveness of the E-PASS score in predicting postoperative complications of RARP. METHODS: A retrospective evaluation was conducted on 204 patients who underwent RARP between 2019 and 2022. Demographic data, parameters indicating patients' preoperative physical condition, and intraoperative risk factors were analyzed. The E-PASS score and subscores were calculated for each patient. RESULTS: Of the patients, 164 (80.4%) were discharged without any postoperative complications (Group 1), and 40 (19.6%) experienced various degrees of complications (Group 2). Patients in Group 2 had higher rates of previous abdominal surgery, elevated Eastern Cooperative Oncology Group (ECOG) performance scores, longer surgical durations, and higher E-PASS scores. To assess the effectiveness of the Comprehensive Risk Score (CRS) as a predictive factor for postoperative complications, a receiver operating characteristic (ROC) curve was constructed with a 95% confidence interval (CI), and a cut-off value was established. The cut-off value for CRS was determined to be -0.0345 (area under the curve [AUC]=0.783, CI: 0.713-0.853; p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Urology, Ankara Bilkent City Hospital, Ankara-Türkiye.
- Department of Urology, Sirnak State Hospital, Sirnak-Türkiye.
- Department of Urology, Ankara Polatli Duatepe State Hospital, Ankara-Türkiye.
- Department of Urology, Konya Cumra State Hospital, Konya-Türkiye.
Zitieren
APA
Bulut, S., Kizilkan, Y., Gültekin, H., Ozercan, A. Y., Köseoğlu, B., Demirçakan, H., Keten, T., Eroğlu, Ü., Güzel, Ö., Tuncel, A., & Özden, C. (2024). Efficiency of the estimation of physiologic ability and surgical stress (E-PASS) score in predicting postoperative complications after robot-assisted radical prostatectomy. Turkish Journal of Trauma and Emergency Surgery. https://doi.org/10.14744/tjtes.2024.36332
Vancouver
Bulut S, Kizilkan Y, Gültekin H, Ozercan AY, Köseoğlu B, Demirçakan H, et al. Efficiency of the estimation of physiologic ability and surgical stress (E-PASS) score in predicting postoperative complications after robot-assisted radical prostatectomy. Turkish Journal of Trauma and Emergency Surgery. 2024. doi:10.14744/tjtes.2024.36332
BibTeX
@article{Bulut2024,
author = {Bulut, Süleyman and Kizilkan, Yalcin and Gültekin, Hüseyin and Ozercan, Ali Yasin and Köseoğlu, Burak and Demirçakan, Halil and Keten, Tanju and Eroğlu, Ünsal and Güzel, Özer and Tuncel, Altug and Özden, Cüneyt},
title = {Efficiency of the estimation of physiologic ability and surgical stress (E-PASS) score in predicting postoperative complications after robot-assisted radical prostatectomy},
journal = {Turkish Journal of Trauma and Emergency Surgery},
year = {2024},
doi = {10.14744/tjtes.2024.36332}
}
EUVIMED